Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 31;8(7):1287-1289.
doi: 10.1016/j.ekir.2023.05.025. eCollection 2023 Jul.

Identifying the Right Target for New Drugs in Acute Kidney Injury: A Long Way Off?

Kent Doi  1
Affiliations
Editorial

Identifying the Right Target for New Drugs in Acute Kidney Injury: A Long Way Off?

Kent Doi. Kidney Int Rep. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Concept of biomarker assignment-driven clinical trial in acute kidney injury.
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.ekir.2023.04.004

References

    1. Miyamoto Y., Iwagami M., Aso S., et al. Temporal change in characteristics and outcomes of acute kidney injury on renal replacement therapy in intensive care units: analysis of a nationwide administrative database in Japan, 2007–2016. Crit Care. 2019;23:172. doi: 10.1186/s13054-019-2468-8. - DOI - PMC - PubMed
    1. Jo S.K., Rosner M.H., Okusa M.D. Pharmacologic treatment of acute kidney injury: why drugs haven’t worked and what is on the horizon. Clin J Am Soc Nephrol. 2007;2:356–365. doi: 10.2215/CJN.03280906. - DOI - PubMed
    1. Kashani K., Al-Khafaji A., Ardiles T., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25. doi: 10.1186/cc12503. - DOI - PMC - PubMed
    1. Meersch M., Schmidt C., Hoffmeier A., et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. 2017;43:1551–1561. doi: 10.1007/s00134-016-4670-3. - DOI - PMC - PubMed
    1. Van Till J.W.O., Nojima H., Kameoka C., et al. The effects of peroxisome proliferator-activated receptor delta modulator ASP1128 in patients at risk for acute kidney injury following cardiac surgery. Kidney Int Rep. 2023;8:1407–1416. - PMC - PubMed

Publication types

LinkOut - more resources